Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

TELA Bio (TELA) Accumulated Depreciation & Amortization (2018 - 2025)

TELA Bio has reported Accumulated Depreciation & Amortization over the past 8 years, most recently at $3.5 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 25.15% year-over-year to $3.5 million; the TTM value through Dec 2025 reached $3.5 million, down 25.15%, while the annual FY2025 figure was $3.5 million, 25.15% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $3.5 million at TELA Bio, down from $4.7 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at $4.7 million in Q4 2024 and troughed at $3.5 million in Q4 2025.
  • A 5-year average of $4.1 million and a median of $4.1 million in 2022 define the central range for Accumulated Depreciation & Amortization.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: increased 10.19% in 2022 and later fell 25.15% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $3.8 million in 2021, then increased by 10.19% to $4.1 million in 2022, then rose by 4.71% to $4.3 million in 2023, then rose by 7.5% to $4.7 million in 2024, then fell by 25.15% to $3.5 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for TELA at $3.5 million in Q4 2025, $4.7 million in Q4 2024, and $4.3 million in Q4 2023.